-

Crescent Capital Group Closes Second European Specialty Lending Fund at Approximately €1.6 Billion

LOS ANGELES & LONDON--(BUSINESS WIRE)--Crescent Capital Group LP, a leading alternative credit investment firm, announced today the final closing of its second European specialty lending fund, Crescent European Specialty Lending Fund II (“CESL II”), with total limited partner equity commitments of approximately €1.6 billion. The fund has both levered and unlevered sleeves. CESL II was meaningfully oversubscribed, exceeding its initial target of €1 billion as well as its initial hard cap. This fundraise represents a significant increase from its predecessor fund, Crescent European Specialty Lending Fund I (“CESL I”), which announced its final close in December 2015 at €500 million of LP capital commitments.

CESL II attracted a diverse mix of international institutional investors including leading global pension funds, insurance companies, financial institutions, foundations, and endowments.

CESL II will continue Crescent’s strategy of investing primarily in a diversified portfolio of private secured debt securities issued by European companies, with a focus on directly-originated transactions. To date, CESL II has committed approximately €400 million across 12 investments.

“The growth in the acceptance of Crescent’s European Specialty Lending strategy is a signal of our consistent and strong performance as well as a testament to the team’s ability to source transactions through our extensive relationship network,” said Christine Vanden Beukel, Managing Director and Head of Crescent’s European Specialty Lending Strategy. “We appreciate our returning and new investors’ confidence in Crescent’s platform to execute on this opportunity.”

“Throughout our long history, making private capital investments has been a significant part of Crescent’s platform as we seek the best risk-adjusted returns for our clients,” said Jean-Marc Chapus, Managing Partner and Co-Founder of Crescent Capital Group. “Crescent has committed the resources to have multinational investment professionals to source, underwrite and collaborate with some of the leading sponsors and family-owned businesses to realize their business objectives.”

Crescent has a track record for investments in below investment grade debt that dates to its founding in 1991 and has been investing in Europe since 1993. To date, Crescent has committed more than €1 billion across more than 30 investments in Europe.

About Crescent Capital Group LP

Crescent Capital Group LP is headquartered in Los Angeles with offices in Boston, London, and New York. With more than 80 investment professionals and approximately 160 employees, the firm invests at all levels of the capital structure, with a significant focus on below investment grade credit through strategies that invest in senior bank loans, high yield debt, mezzanine debt, distressed debt, and other private debt securities. As of December 31, 2019, Crescent Capital Group LP managed approximately $28 billion in assets.

Contacts

Mendel Communications
Bill Mendel, +1 212-397-1030
bill@mendelcommunications.com

Crescent Capital Group LP


Release Versions

Contacts

Mendel Communications
Bill Mendel, +1 212-397-1030
bill@mendelcommunications.com

More News From Crescent Capital Group LP

Crescent European Specialty Lending Leads Financing to Support ECI Partners’ Acquisition of Paragin

LONDON & LOS ANGELES--(BUSINESS WIRE)--Crescent Capital Group LP, one of the leading alternative credit investment firms, announced today that its European Specialty Lending strategy led the financing to support the acquisition of Paragin, a leading provider of exam and assessment software, by U.K.-headquartered mid-market private equity firm ECI Partners from Main Capital Partners. Based in the Netherlands, Paragin delivers an integrated suite of software solutions that support high-stakes exa...

Crescent Closes $3.2 Billion Private Credit Continuation Vehicle

LOS ANGELES & NEW YORK--(BUSINESS WIRE)--Crescent Capital Group LP, one of the leading alternative credit investment firms, and Pantheon, one of the leading global private markets investors, today announced the closing of Crescent Credit Solutions VII CV (“CCS VII CV”), a $3.2 billion private credit continuation vehicle. CCS VII CV was established to acquire a diversified portfolio of performing sponsor-backed loans and securities and other equity interests from Crescent Mezzanine Partners VII,...

Crescent European Specialty Lending Provides Financing to Support Apheon-Led Buy-and-Build Platform in Trenchless Pipe Rehabilitation Market

LONDON & LOS ANGELES--(BUSINESS WIRE)--Crescent Capital Group LP, one of the leading alternative credit investment firms, announced today that its European Specialty Lending strategy has provided financing to pan-European mid-market private equity firm Apheon and the founders of several Germany-based pipe rehabilitation and manufacturing companies (including IMS Group, resinnovation, Polypipe, Amex Sanivar, Hurricane Trenchless Technologie, Kardiam). The financing supports the consolidation of...
Back to Newsroom